Tilganga Institute of Ophthalmology Gets $930 Thousand Grant to Double IOL Production

May 11, 2018: By Joan McKenna

The Tilganga Institute of Ophthalmology in Nepal has received a $930 thousand government grant ($100 million Nepalese rupees) to double production capacity for intraocular lenses, the institute announced May 10.

Tilganga said in 2017 that it produced lenses at a rate of 500 thousand per year, with a total of 4.9 million IOLs sold in more than 50 countries since it opened its doors in 1994.

Nepal native Sanduk Ruit, MD, helped found Tilganga with the mission to provide high-quality care in places considered poor by Western standards. The facility’s lenses cost as little as $3.

Ruit waives surgery fees for those unable to pay and treks to remote parts of Nepal and throughout the Himalayas to treat patients who can’t travel to the facility. Ruit and colleagues from Tilganga have traveled as far as North Korea, Cambodia, Bangladesh, Vietnam, Ethiopia, and Ghana.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

China’s Innovent Plans $500 Million IPO on Hong Kong Exchange

FDA Accepts Bausch + Lomb’s NDA Filing for Loteprednol Etabonate Ophthalmic Gel

Allergan Launches Refresh Repair Lubricant Eye Drops

US Federal Trade Commission Approves Takeda’s Bid for Shire

Nikon to Acquire Ophthalmic Distributor Chuo Sangio to Merge with Optos Subsidiary

Wills Eye Hospital to Use $5 Million Gift to Support Expansion

Pixium Vision’s PRIMA Implanted in Five Patients with Atrophic Dry AMD

Iuvo BioScience Acquires Oculos Clinical Research

Alcon Will Be Worth $20 Billion to $30 Billion After Spinoff, Novartis Chairman Says

Katena Acquires Blink Medical, Adding to String of Recent Purchases

Opthea’s Phase IIb Trial for Wet AMD Candidate Reaches Midway Point for Enrollment

Ocugen Starts Phase III Trial of OCU300 for Ocular Graft Versus Host Disease

Oculocare Medical Receives US FDA 510(k) Approval for ALLEYE, an Amsler Grid App

Santen Ventures Invests $1 Million in Qura’s QSmart System

Elsalys Biotech Says New Studies Confirm Anti-CD160 Potential in Ophthalmology

Eyedaptic Presents Augmented Reality Glasses for AMD at OCTANe Summit

Quantel Medical Launches Vitra 2 Photocoagulator

Novartis Announces Plans to Spin Off Alcon

Glaukos Announces FDA Approval of iStent Inject for Lowering IOP

Aerpio Prices $45M Public Offering, Moves to Nasdaq Capital Market

Coming soon

2018 Glaucoma Device Report: A Global Market Analysis for 2017 to 2023